Vault-13

Kalehua Capital Management LLC

DALLAS, TX · CIK 2106181 · 13F filing filed 2026-05-15

Exempt reporting adviser since 2023 · limited liability company

$259.9m reported value +157.1% vs Q4 2025
25positions
72.1%in top 10
9 new 16 added 0 reduced 3 sold out vs Q4 2025

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 EA SERIES TRUST ALPHA ARCH 1-3 BOXX BOXX 336,700 $39.2m15.06% 15.06% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 230.8k, Q1 2026 336.7k +105.9k +105,913 45.9%
2 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 7,445,680 $30.8m11.83% 11.83% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 3.7m, Q1 2026 7.4m +3.7m +3,722,840 100.0%
3 SURROZEN INC COM NEW SRZN SRZN 770,356 $22.4m8.63% 8.63% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 385.2k, Q1 2026 770.4k +385.2k +385,178 100.0%
4 RELAY THERAPEUTICS INC COM RLAY RLAY 1,802,914 $17.9m6.90% 6.90% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 901.5k, Q1 2026 1.8m +901.5k +901,457 100.0%
5 SIONNA THERAPEUTICS INC COM SION SION 394,144 $15.8m6.08% 6.08% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 197.1k, Q1 2026 394.1k +197.1k +197,072 100.0%
6 VERADERMICS INC COMMON STOCK MANE MANE 248,574 $15.7m6.04% 6.04% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 248.6k
7 ACLARIS THERAPEUTICS INC COM ACRS ACRS 3,169,921 $11.9m4.57% 4.57% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 3.2m
8 ORUKA THERAPEUTICS INC COM ORKA ORKA 237,048 $11.6m4.47% 4.47% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 118.5k, Q1 2026 237.0k +118.5k +118,524 100.0%
9 PHARVARIS N V COM PHVS PHVS 397,544 $11.2m4.32% 4.32% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 198.8k, Q1 2026 397.5k +198.8k +198,772 100.0%
10 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 6,494,498 $10.9m4.20% 4.20% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 1.8m, Q1 2026 6.5m +4.7m +4,744,498 271.1%
11 SEPTERNA INC COM SEPN SEPN 389,088 $9.3m3.60% 3.60% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 194.5k, Q1 2026 389.1k +194.5k +194,544 100.0%
12 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 1,639,384 $9.1m3.49% 3.49% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 819.7k, Q1 2026 1.6m +819.7k +819,692 100.0%
13 UNIQURE NV SHS QURE QURE 502,811 $8.2m3.16% 3.16% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 502.8k
14 LEONABIO INC COM LONA LONA 787,402 $8.1m3.11% 3.11% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 393.7k, Q1 2026 787.4k +393.7k +393,701 100.0%
15 DAMORA THERAPEUTICS INC COM NEW COM NEW 278,000 $7.2m2.77% 2.77% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 278.0k
16 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 351,468 $6.6m2.52% 2.52% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 175.7k, Q1 2026 351.5k +175.7k +175,734 100.0%
17 GOSSAMER BIO INC COM GOSS GOSS 17,708,133 $5.8m2.24% 2.24% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 17.7m
18 TYRA BIOSCIENCES INC COM TYRA TYRA 148,930 $5.7m2.19% 2.19% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 74.5k, Q1 2026 148.9k +74.5k +74,465 100.0%
19 PEPGEN INC COM PEPG PEPG 1,729,961 $3.1m1.18% 1.18% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 1.7m
20 TENAYA THERAPEUTICS INC COM TNYA TNYA 4,000,000 $2.8m1.07% 1.07% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 2.0m, Q1 2026 4.0m +2.0m +2,000,000 100.0%
21 INSTIL BIO INC COM NEW TIL TIL 322,879 $2.7m1.02% 1.02% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 322.9k
22 KALARIS THERAPEUTICS INC COM KLRS KLRS 271,170 $1.6m0.60% 0.60% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 139.9k, Q1 2026 271.2k +131.3k +131,269 93.8%
23 KORRO BIO INC COM KRRO KRRO 109,376 $1.2m0.48% 0.48% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 109.4k
24 DIAMEDICA THERAPEUTICS INC COM NEW DMAC DMAC 124,976 $846.1k0.33% 0.33% AddedShares held: Q2 2025 —, Q3 2025 —, Q4 2025 95.4k, Q1 2026 125.0k +29.6k +29,617 31.1%
25 LOOP INDS INC COM LOOP LOOP 347,539 $361.4k0.14% 0.14% NewShares held: Q2 2025 —, Q3 2025 —, Q4 2025 0, Q1 2026 347.5k

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
ALLOGENE THERAPEUTICS INC ALLO ALLO 2,546,129 $3.5m2.5m shares
ORIC PHARMACEUTICALS INC ORIC ORIC 267,059 $2.2m267.1k shares
VERRICA PHARMACEUTICALS INC VRCA VRCA 235,779 $2.0m235.8k shares